Oral Semaglutide under Human Protocols and Doses Regulates Food Intake, Body Weight, and Glycemia in Diet-Induced Obese Mice

The first oral form of the glucagon-like peptide-1 receptor agonist, oral semaglutide, has recently been launched and potently controls glycemia and body weight in subjects with type 2 diabetes. This drug carries the absorption enhancer and requires specific protocols of administration. The mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakhat, Yermek, Wang, Lei, Han, Wanxin, Rustemova, Aktolkyn, Kulzhanova, Nazymgul, Yamada, Yuichiro, Yabe, Daisuke, Seino, Yutaka, Yada, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489807/
https://www.ncbi.nlm.nih.gov/pubmed/37686797
http://dx.doi.org/10.3390/nu15173765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489807/
https://www.ncbi.nlm.nih.gov/pubmed/37686797
http://dx.doi.org/10.3390/nu15173765

Ejemplares similares